Introduction.
作者信息
Robert Jacques
机构信息
Department of Microbiology & Immunology, University of Rochester Medical Center , Rochester, NY , USA.
出版信息
Immunol Invest. 2019 Oct;48(7):680-681. doi: 10.1080/08820139.2019.1645983.
Abstract
摘要
相似文献
1
Introduction.引言。
Immunol Invest. 2019 Oct;48(7):680-681. doi: 10.1080/08820139.2019.1645983.
2
Immunotherapy of human cancer: lessons from mice.人类癌症的免疫疗法：来自小鼠的经验教训。
Nat Immunol. 2000 Nov;1(5):363-6. doi: 10.1038/808795.
3
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects.免疫疗法在人类实体瘤治疗中的应用：基础与转化研究方面
J Immunol Res. 2016;2016:7853028. doi: 10.1155/2016/7853028. Epub 2016 Jun 1.
4
Updates to the antitumor mechanism of oncolytic virus.肿瘤溶瘤病毒抗肿瘤机制的研究进展。
Thorac Cancer. 2019 May;10(5):1031-1035. doi: 10.1111/1759-7714.13043. Epub 2019 Mar 22.
5
Editorial overview: Tumour immunology: Are we on the path to win the battle against cancer through immunotherapy?编辑概述：肿瘤免疫学：我们正走在通过免疫疗法战胜癌症的道路上吗？
Curr Opin Immunol. 2018 Apr;51:vii-ix. doi: 10.1016/j.coi.2018.04.018.
6
Interferon α in cancer immunoediting: From elimination to escape.干扰素 α 在癌症免疫编辑中的作用：从消除到逃逸。
Scand J Immunol. 2020 May;91(5):e12863. doi: 10.1111/sji.12863. Epub 2020 Feb 5.
7
Anti-cancer immunotherapy: breakthroughs and future strategies.抗癌免疫疗法：突破与未来策略
Semin Immunopathol. 2019 Jan;41(1):1-3. doi: 10.1007/s00281-018-0711-z. Epub 2018 Sep 21.
8
Safety Starts with Selecting the Targets.安全始于选择目标。
Mol Ther. 2021 Feb 3;29(2):424-425. doi: 10.1016/j.ymthe.2021.01.011. Epub 2021 Jan 12.
9
Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers.癌症免疫疗法以及预后和预测生物标志物的鉴定
Biomed Res Int. 2018 Mar 20;2018:5184075. doi: 10.1155/2018/5184075. eCollection 2018.
10
Cancer immunotherapy: challenges and clinical applications.癌症免疫疗法：挑战与临床应用
J Med Genet. 2019 Jan;56(1):1-3. doi: 10.1136/jmedgenet-2018-105852. Epub 2018 Nov 21.
本文引用的文献
1
Evolutionary Underpinnings of Innate-Like T Cell Interactions with Cancer.先天样 T 细胞与癌症相互作用的进化基础。
Immunol Invest. 2019 Oct;48(7):737-758. doi: 10.1080/08820139.2019.1631341. Epub 2019 Jun 21.
2
Devil Facial Tumours: Towards a Vaccine.恶魔面部肿瘤：走向疫苗。
Immunol Invest. 2019 Oct;48(7):719-736. doi: 10.1080/08820139.2019.1624770. Epub 2019 Jun 4.
3
Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines.丁酸钠作为组蛋白去乙酰化酶抑制剂影响结直肠癌细胞系中 Toll 样受体 4 的表达。
Immunol Invest. 2019 Oct;48(7):759-769. doi: 10.1080/08820139.2019.1595643. Epub 2019 May 23.
4
The Expression of ILT4 in Myeloid Dendritic Cells in Patients with Hepatocellular Carcinoma.白细胞免疫球蛋白样受体 4 在肝癌患者树突状细胞中的表达。
Immunol Invest. 2019 Oct;48(7):704-718. doi: 10.1080/08820139.2019.1571507. Epub 2019 May 2.
5
Cloning and Analysis of the Multiple Transcriptomes of Serine Protease Homologs in Crayfish ().克氏原螯虾丝氨酸蛋白酶同源基因的多个转录本的克隆与分析（）。
Immunol Invest. 2019 Oct;48(7):682-690. doi: 10.1080/08820139.2018.1509870. Epub 2019 Feb 22.
6
TNF May Negatively Regulate Phagocytosis of Devil Facial Tumour Disease Cells by Activated Macrophages.肿瘤坏死因子可能通过激活的巨噬细胞负调控对魔鬼面部肿瘤病细胞的吞噬作用。
Immunol Invest. 2019 Oct;48(7):691-703. doi: 10.1080/08820139.2018.1515222. Epub 2019 Jan 19.
7
Cancer across the tree of life: cooperation and cheating in multicellularity.生命之树上的癌症：多细胞生物中的合作与欺骗
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673). doi: 10.1098/rstb.2014.0219.
8
Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates.无脊椎动物和非哺乳动物脊椎动物的肿瘤发生和肿瘤免疫的比较研究。
Dev Comp Immunol. 2010 Sep;34(9):915-25. doi: 10.1016/j.dci.2010.05.011. Epub 2010 Jun 2.
Zotero 插件